Treating Snake Envenomation in India: A Costing Analysis for the Adoption of a Small Molecule Therapeutic

Investigator: Simran Dhanju, MS
Sponsor: Global Health Sciences Education

Location(s): India


Snake envemonation kills as estimated 50,000 individuals each year in India alone. This extremely high mortality rate is primarily the result of poor availability and deliverance of anti-venom in rural areas. A novel solution to the neglected burden of snake envenomation is the use of small molecule inhibitors. Such compounds have been shown to be efficacious in humans and are potentially cost-effective if they can be delivered below a threshold cost. The purpose of this study is to evaluate the production, distribution and research costs of a single small molecule in clinical setting in Northern India.